Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and
Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and corporate development activities. Venkatadri's promotion culminated a succession plan agreed upon when he was hired in November 1995, according to the San Diego-based company.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.